欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2019, Vol. 24 ›› Issue (7): 750-758.doi: 10.12092/j.issn.1009-2501.2019.07.005

• 基础研究 • 上一篇    下一篇

珠子参皂苷通过激活 PI3K/Akt通路对小鼠脑缺血再灌注损伤的保护作用研究

段晋宁1, 向常清2, 钱爱红1, 李 进1, 陈修全1, 韩永峰1, 黄 娜1, 范丽莉3   

  1. 1神农架林区人民医院内1科,神农架 442400,湖北; 2三峡大学第二人民医院&宜昌市第二人民医院重症医学科,宜昌 443000,湖北; 3三峡大学附属仁和医院重症医学科,宜昌 443001,湖北
  • 收稿日期:2019-01-02 修回日期:2019-06-02 出版日期:2019-07-26 发布日期:2019-07-29
  • 通讯作者: 向常清,男,本科,主任医师,硕士研究生导师,研究方向:心脑血管疾病的基础与临床研究。 Tel: 0717-6211080 E-mail: 228339163@qq.com
  • 作者简介:段晋宁,女,本科,主任医师,研究方向:心脑血管疾病基础与临床研究。 Tel: 0719-3337837 E-mail: 34418224@qq.com
  • 基金资助:

    神农架林区科学技术局项目([2015]33-2)

Saponins from Rhizoma Panacis Majoris protect against cerebral ischemia and reperfusion injury through modulation of PI3K/Akt signaling pathway in mice

DUAN Jinning1, XIANG Changqing2, QIAN Aihong1, LI Jin1, CHEN Xiuquan1, HAN Yongfeng1, HUANG Na1, FAN Lili3   

  1. 1 Shennongjia Forest District People's Hospital, Shennongjia 442400, Hubei,China; 2 The Second People's Hospital, China Three Gorges University &Yichang Second Hospital, Yichang 443000, Hubei,China; 3 China Three Gorges University affiliated Renhe Hospital, Yichang 443001, Hubei, China
  • Received:2019-01-02 Revised:2019-06-02 Online:2019-07-26 Published:2019-07-29

摘要:

目的: 研究珠子参皂苷对小鼠脑缺血再灌注损伤的保护作用及可能机制。方法:雄性昆明小鼠随机分为假手术组、模型组、珠子参皂苷(100 mg/kg)、珠子参皂苷(200 mg/kg)和尼莫地平组(2 mg/kg)。给药组灌胃给予相应的药物,假手术组和模型组灌胃给予同体积0.5%羧甲基纤维素钠溶液,每天1次,连续7 d。以上各组给药7 d后制作小鼠大脑中动脉闭塞模型,假手术组切开缝合不进行动脉阻塞,在缺血2 h再灌注24 h后进行神经功能缺损评分、脑水肿、梗死面积和脑组织形态学分析,血液中ROS、LDH、SOD、GSH-Px、CAT和MDA的水平检测,Western blot检测脑组织中p-PI3K、PI3K、p-Akt、Akt、Bcl-2、Bax、Cytochrome C、cleaved-caspase-9和cleaved-caspase-3蛋白表达。结果:珠子参皂苷(100和200 mg/kg)和尼莫地平(2 mg/kg)可显著改善脑缺血再灌注损伤小鼠神经功能缺损评分、脑水肿、梗死面积和脑组织形态学,降低血清ROS、LDH和MDA水平,升高SOD、GSH-Px、CAT活性,上调脑组织中p-PI3K、p-Akt、Bcl-2蛋白表达和升高Bcl-2/Bax比率,下调Bax、Cytochrome C、cleaved-caspase-9和cleaved-caspase-3蛋白表达。结论:珠子参皂苷对小鼠缺血再灌注损伤具有较好的保护作用,其作用机制可能与其激活PI3K/Akt通路和抑制线粒体介导的凋亡通路有关。

关键词: 珠子参皂苷, 脑缺血再灌注损伤, 氧化应激, PI3K/Akt和线粒体介导的凋亡通路

Abstract:

AIM: To study the protective effect and possible mechanism of saponins from Rhizoma Panacis Majoris (SRPM) on cerebral ischemia-reperfusion (I/R) injury in mice. METHODS: Male Kunming mice were randomly divided into sham operation group, model group, SRPM (100 mg/kg), SRPM (200 mg/kg) and nimodipine group (2 mg/kg). The drug groups were given corresponding drugs by gavage, while the sham operation group and the model group were given 0.5% sodium carboxymethyl cellulose solution by gavage once a day for 7 consecutive days. After 7 days of administration, the middle cerebral artery occlusion model was established in mice in the sham operation group. After 2 hours of ischemia and 24 hours of reperfusion, the neurological deficit score, brain edema, infarct area and brain histomorphology were analyzed. The levels of ROS, LDH, SOD, GSH-Px, CAT and MDA in blood were detected. The protein levels of p-PI3K, PI3K, p-Akt, Akt Bcl-2, Bax, cytochrome C, cleaved-caspase-9 and cleaved-caspase-3 in brain tissue were detected by Western blot. RESULTS:SRPM (100 and 200 mg/kg) and nimodipine (2 mg/kg) could significantly improve neurological deficit score, brain edema, infarct area and brain histomorphology in cerebral I/R injury mice, reduce the levels of ROS, LDH and MDA, increase SOD, GSH-Px, CAT activities in serum, up-regulate the protein expressions of p-PI3K, p-Akt, Bcl-2, and Bcl-2/Bax ratio, down-regulate the protein expressions of Bax, cytochrome C, cleaved-caspase-9 and cleaved-caspase-3. CONCLUSION: The protective effect of SRPM on I/R injury mice may be related to its activation of PI3K/Akt pathway and inhibition of mitochondrial-mediated apoptotic pathway.

Key words: Saponins from Rhizoma Panacis Majoris, cerebral ischemia and reperfusion injury, oxidative stress, PI3K/Akt signaling pathway and mitochondrial-mediated apoptotic pathway

中图分类号: